FILTRIX Logo FILTRIX Find Your Edge β†’
Sector Report β€” Open SIC 2836 Β· 130 tickers

Biological Products, (No Diagnostic Substances)

SIC 2836 130 tickers analyzed 3,599 total alerts

Tickers
130
In this sector
Total alerts
3,599
Trade-Ideas signal history
Avg win rate
43.9%
Sector baseline
Avg gain
-0.54%
Per-alert expectancy

πŸ“ˆ Sector Performance by Timeframe

5-Minute

Avg Gain: -0.40%
Win Rate: 39.9%

15-Minute

Avg Gain: -0.58%
Win Rate: 41.1%

30-Minute

Avg Gain: -0.62%
Win Rate: 41.4%

60-Minute

Avg Gain: -0.78%
Win Rate: 41.9%

EOD

Avg Gain: -0.31%
Win Rate: 55.3%

MFE/MAE

Avg MFE: +6.62%
Avg MAE: -2.75%

πŸ“‹ Biological Products, (No Diagnostic Substances) Stocks (100)

All tickers in SIC 2836 with Trade-Ideas alert data, sorted by alert count.

# Ticker Company Market Cap Alerts Avg Win Rate Avg 5min MFE Action
1 DNA Ginkgo Bioworks Holdings, Inc. $519.2M 436 43.2% -0.59% +4.00% View β†’
2 OCGN Ocugen, Inc. Common Stock $501.9M 332 38.4% -0.63% +3.63% View β†’
3 NVAX Novavax Inc $1.45B 312 44.0% -0.27% +5.20% View β†’
4 MRNA Moderna, Inc. Common Stock $69.62B 173 50.0% +0.07% +3.82% View β†’
5 RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock $1.88B 147 44.8% -0.46% +4.58% View β†’
6 GILD Gilead Sciences Inc $183.02B 138 57.2% +0.10% +1.26% View β†’
7 PALI Palisade Bio, Inc. Common Stock $376.4M 118 42.1% -0.18% +9.75% View β†’
8 OTLK Outlook Therapeutics, Inc. Common Stock $167.5M 84 53.8% -0.01% +10.10% View β†’
9 AMGN Amgen Inc $239.32B 82 53.4% +0.03% +1.16% View β†’
10 IBRX ImmunityBio, Inc. Common Stock $8.62B 79 44.6% -0.97% +9.39% View β†’
11 SGMO SANGAMO THERAPEUTICS INC - 75 44.8% +0.12% +9.76% View β†’
12 PLX Protalix BioTherapeutics, Inc. Common Stock $189.3M 64 44.7% -0.23% +4.59% View β†’
13 IOVA Iovance Biotherapeutics, Inc. Common Stock $3.62B 63 43.5% -0.33% +4.85% View β†’
14 SNTI Senti Biosciences Holdings, Inc. Common Stock $14.4M 57 42.1% -0.80% +17.26% View β†’
15 XFOR X4 Pharmaceuticals, Inc. Common Stock $412.5M 57 38.2% -1.96% +8.62% View β†’
16 CELZ Creative Medical Technology Holdings, Inc. Common Stock $7.4M 51 42.2% -0.16% +9.61% View β†’
17 CHRS Coherus Oncology, Inc. Common Stock $205.5M 47 42.1% -0.37% +6.39% View β†’
18 TVGN Tevogen Inc. Common Stock $27.1M 44 35.0% -0.26% +12.36% View β†’
19 BIIB Biogen Inc. Common Stock $32.74B 43 43.7% -0.38% +1.24% View β†’
20 ATRA Atara Biotherapeutics, Inc $96.4M 41 59.6% +0.56% +11.12% View β†’
21 CGTX Cognition Therapeutics, Inc. Common Stock $93.1M 40 38.5% -0.94% +8.30% View β†’
22 AGEN Agenus Inc. $371.8M 39 51.3% -0.53% +5.35% View β†’
23 DBVT DBV Technologies S.A. $928.9M 39 45.5% -0.03% +6.61% View β†’
24 CRIS Curis Inc $4.2M 33 35.2% -0.96% +6.76% View β†’
25 TSHA Taysha Gene Therapies, Inc. Common Stock $2.10B 32 39.4% -0.56% +9.76% View β†’
26 SLXN Silexion Therapeutics Corp Ordinary Shares $2.3M 30 42.7% -1.23% +12.55% View β†’
27 TNYA Tenaya Therapeutics, Inc. Common Stock $159.9M 30 38.7% -0.48% +7.07% View β†’
28 INAB IN8bio, Inc. Common Stock $11.8M 29 42.0% -0.66% +10.13% View β†’
29 SCLX Scilex Holding Company Common Stock $39.7M 29 44.8% -0.75% +7.03% View β†’
30 BCRX BioCryst Pharmaceuticals Inc $2.57B 25 60.0% -0.21% +6.68% View β†’
31 HUMA Humacyte, Inc. Common Stock $204.2M 25 44.8% -0.39% +7.22% View β†’
32 SLDB Solid Biosciences Inc. Common Stock $1.04B 25 54.4% -0.46% +9.05% View β†’
33 CADL Candel Therapeutics, Inc. Common Stock $1.03B 24 49.9% +1.30% +15.67% View β†’
34 DTIL Precision BioSciences, Inc. Common Stock $234.6M 24 42.0% -0.70% +4.55% View β†’
35 BCDA BioCardia, Inc. Common Stock $15.0M 23 37.3% -0.08% +8.59% View β†’
36 CCCC C4 Therapeutics, Inc. $517.9M 23 57.4% +0.93% +16.24% View β†’
37 CRSP CRISPR Therapeutics AG $5.78B 23 47.8% -0.34% +4.61% View β†’
38 CVM Cel-Sci Corporation $28.8M 23 44.3% +0.39% +14.95% View β†’
39 CRDF Cardiff Oncology, Inc. Common Stock $69.9M 22 39.4% +1.06% +9.83% View β†’
40 JSPR Jasper Therapeutics, Inc. Common Stock $24.8M 20 51.0% +0.37% +17.19% View β†’
41 IVVD Invivyd, Inc. Common Stock $282.8M 20 40.0% -1.59% +21.23% View β†’
42 BDTX Black Diamond Therapeutics, Inc. Common Stock $125.8M 20 24.0% -1.25% +6.13% View β†’
43 AIM AIM ImmunoTech Inc. $7.3M 19 35.1% -0.19% +5.34% View β†’
44 IKT Inhibikase Therapeutics, Inc. Common Stock $341.9M 17 38.5% -0.97% +8.23% View β†’
45 CRBU Caribou Biosciences, Inc. Common Stock $175.8M 16 30.0% -1.02% +4.77% View β†’
46 CABA Cabaletta Bio, Inc. Common Stock $525.6M 16 33.8% -1.14% +12.54% View β†’
47 CLDI Calidi Biotherapeutics, Inc. $3.6M 15 30.7% -2.21% +13.97% View β†’
48 PHGE BiomX Inc. $1.5M 15 49.7% +0.08% +11.53% View β†’
49 NBIX Neurocrine Biosciences Inc $15.81B 14 65.7% +0.14% +1.75% View β†’
50 ADMA ADMA Biologics, Inc. $2.25B 14 57.1% +0.27% +6.88% View β†’
51 SANA Sana Biotechnology, Inc. Common Stock $1.23B 14 45.7% +1.47% +8.65% View β†’
52 ALGS Aligos Therapeutics, Inc. Common Stock $43.0M 14 45.4% -2.25% +8.20% View β†’
53 QNCX Quince Therapeutics, Inc. Common Stock $35.2M 14 26.2% -2.24% +7.08% View β†’
54 BCAB BioAtla, Inc. Common Stock $5.4M 13 26.5% -1.38% +8.39% View β†’
55 AVXL Anavex Life Sciences $314.2M 13 23.1% -1.47% +5.25% View β†’
56 EDIT Editas Medicine, Inc. Common Stock $499.1M 13 43.1% -0.94% +6.19% View β†’
57 IMVT Immunovant, Inc. Common Stock $9.29B 12 56.7% +0.71% +8.78% View β†’
58 SABS SAB Biotherapeutics, Inc. Common Stock $343.9M 12 42.7% -2.22% +14.60% View β†’
59 VIR Vir Biotechnology, Inc. Common Stock $1.65B 12 25.0% -1.46% +4.22% View β†’
60 SRZN Surrozen, Inc. Common $282.2M 11 54.0% -0.50% +14.11% View β†’
61 KOD Kodiak Sciences Inc Common Stock $2.52B 11 60.0% +0.02% +13.78% View β†’
62 FDMT 4D Molecular Therapeutics, Inc. Common Stock $925.9M 10 32.0% -2.37% +6.07% View β†’
63 NMRA Neumora Therapeutics, Inc. Common Stock $308.1M 10 61.3% +0.65% +8.94% View β†’
64 TCRX TScan Therapeutics, Inc. Common Stock $50.8M 10 53.1% +0.22% +25.40% View β†’
65 LCTX Lineage Cell Therapeutics, Inc. $278.2M 10 20.4% -0.71% +3.29% View β†’
66 HALO Halozyme Therapeutics, Inc. $12.21B 10 30.2% -1.07% +1.45% View β†’
67 ABOS Acumen Pharmaceuticals, Inc. Common Stock $227.8M 10 28.0% -0.70% +8.74% View β†’
68 FATE Fate Therapeutics, Inc. $317.5M 9 55.6% +3.69% +14.54% View β†’
69 RVMD Revolution Medicines, Inc. Common Stock $46.01B 9 51.1% -2.20% +4.88% View β†’
70 TECH Bio-Techne Corp. $11.29B 8 47.9% -0.00% +1.24% View β†’
71 RLAY Relay Therapeutics, Inc. Common Stock $4.54B 8 42.5% +0.17% +8.40% View β†’
72 AUTL Autolus Therapeutics plc American Depositary Share $676.1M 8 22.5% -0.53% +3.79% View β†’
73 BEAM Beam Therapeutics Inc. Common Stock $3.00B 8 55.0% +0.14% +8.05% View β†’
74 ALLO Allogene Therapeutics, Inc. Common Stock $770.4M 8 27.5% +0.55% +6.56% View β†’
75 EXEL Exelixis Inc $13.48B 7 65.7% -0.11% +1.54% View β†’
76 PMCB PharmaCyte Biotech, Inc. Common Stock $5.7M 7 20.0% -0.30% +2.05% View β†’
77 PCVX Vaxcyte, Inc. Common Stock $9.42B 7 51.4% +0.64% +6.08% View β†’
78 PASG Passage Bio, Inc. Common Stock $14.5M 7 65.7% +0.12% +14.14% View β†’
79 STRO Sutro Biopharma, Inc. $363.3M 6 36.7% -1.31% +6.30% View β†’
80 TIL Instil Bio, Inc. Common Stock $50.1M 6 60.0% +0.68% +5.13% View β†’
81 DNLI Denali Therapeutics Inc. Common Stock $4.11B 6 33.3% -1.06% +4.83% View β†’
82 INBX Inhibrx Biosciences, Inc. Common Stock $1.49B 6 64.7% +0.47% +6.34% View β†’
83 ENTX Entera Bio Ltd. Ordinary Shares $538.5M 6 28.0% -0.96% +9.40% View β†’
84 TWST Twist Bioscience Corporation Common Stock $8.93B 6 36.7% -0.76% +4.84% View β†’
85 SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares $1.4M 6 27.3% +2.64% +10.82% View β†’
86 ZURA Zura Bio Limited Class A Ordinary Shares $559.6M 6 43.3% -0.10% +16.82% View β†’
87 REPL Replimune Group, Inc. $1.40B 5 68.0% -1.10% +7.54% View β†’
88 ACLX Arcellx, Inc. Common Stock $3.91B 5 28.0% -1.21% +4.45% View β†’
89 SRRK Scholar Rock Holding Corporation Common Stock $6.88B 5 32.0% +0.26% +9.98% View β†’
90 VOR Vor Biopharma Inc. Common Stock $1.40B 5 52.0% +2.16% +23.07% View β†’
91 MGX Metagenomi Therapeutics, Inc. Common Stock $46.8M 5 40.0% +3.16% +23.51% View β†’
92 RGNX REGENXBIO Inc. $793.5M 4 30.0% -2.90% +2.05% View β†’
93 PROK ProKidney Corp. Class A Ordinary Shares $309.2M 4 35.0% -1.14% +8.42% View β†’
94 CGEM Cullinan Therapeutics, Inc. Common Stock $1.45B 4 15.0% -1.77% +2.69% View β†’
95 TARS Tarsus Pharmaceuticals, Inc. Common Stock $3.22B 4 25.0% -1.94% +1.96% View β†’
96 INKT MiNK Therapeutics, Inc. Common Stock $56.8M 4 41.7% -3.04% +11.47% View β†’
97 TARA Protara Therapeutics, Inc. Common Stock $234.0M 4 40.0% -0.06% +10.04% View β†’
98 ELUT Elutia Inc. Class A Common Stock $40.9M 4 60.0% +0.88% +18.35% View β†’
99 CMPX Compass Therapeutics, Inc. Common Stock $446.6M 4 25.0% -2.00% +18.76% View β†’
100 KLTO Klotho Neurosciences, Inc. Common Stock $23.7M 4 20.0% +0.45% +10.33% View β†’

πŸš€ Scan for Alpha in Biological Products, (No Diagnostic Substances)

Don't trade the whole basket.
Use FILTRIX to isolate the top performing stocks among the 130 companies in this sector. Filter by MFE, Volume, and Win Rate instantly.

Find Best Setups β†’

πŸ“Š Biological Products, (No Diagnostic Substances) Sector Intelligence

⚑ High Volatility Sector

The Biological Products, (No Diagnostic Substances) sector (SIC 2836) aggregates data from 130 stocks. With an average Maximum Favorable Excursion (MFE) of +6.62%, this sector is highly aggressive, suited for experienced volatility traders looking for explosive moves.

πŸ“ˆ Statistical Expectancy

Across 3,599 analyzed alerts, the sector shows a 43.9% Win Rate with an average gain of -0.54%.

⚠️ This suggests a difficult trading environment where strict stock selection is critical. Focus on the top performers within this sector.

πŸ† Sector Leader

The strongest statistical performer in this group is currently NBIX , boasting a 65.7% win rate across 14 alerts.

This significantly outperforms the sector average (43.9%), making it a primary watchlist candidate for traders seeking edge in this space.